GlobalData on MSN
Lynx Dx launches MPS2 prostate cancer test for at-home collection
Lynx Dx has commercially launched MyProstateScore 2.0 (MPS2), a urine test kit for prostate cancer intended for at-home ...
Active surveillance is widely used for men with low-risk prostate cancer, but existing tools have important limitations and monitoring relies on repeated biopsies that burden patients and practices.
ANN ARBOR, Mich., Feb. 03, 2025 /PRNewswire/ -- Lynx Dx, a leader in innovative diagnostic solutions, announced today that its pioneering MyProstateScore 2.0 (MPS2) will be made available for at-home ...
Study finds MPS2 scores are highly reproducible across DRE and non-DRE urine samples alike. “This study reinforces the value of MPS2 as a non-invasive diagnostic tool that delivers consistent and ...
An experimental urine test can detect aggressive prostate cancers in men on active surveillance, potentially sparing them from repeated biopsies, researchers reported on Friday. The MPS2-AS test is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results